Back to SYRE
FRANKLIN TEMPLETON INC SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
12
Latest value
$17.8M
Q3 2026
Peak value
$95.3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $2K |
| Q4 2025 | $36.3M |
| Q1 2026 | $3K |
| Q1 2026 | $44.5M |
| Q2 2026 | $5K |
| Q2 2026 | $90.6M |
| Q2 2026 | $25M |
| Q2 2026 | $15.1M |
| Q3 2026 | $8K |
| Q3 2026 | $95.3M |
| Q3 2026 | $29.1M |
| Q3 2026 | $17.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $17.8M | 180.1K | — | — |
| Q3 2026 | $29.1M | 293.7K | — | — |
| Q3 2026 | $95.3M | 961.9K | — | — |
| Q3 2026 | $8K | 85 | — | — |
| Q2 2026 | $15.1M | 170.6K | — | — |
| Q2 2026 | $25M | 281.3K | — | — |
| Q2 2026 | $90.6M | 1.02M | — | — |
| Q2 2026 | $5K | 55 | — | — |
| Q1 2026 | $44.5M | 882.8K | — | — |
| Q1 2026 | $3K | 55 | — | — |
| Q4 2025 | $36.3M | 1.11M | — | — |
| Q4 2025 | $2K | 47 | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M
$336.7M